The drugs industry closed the day up 1.9%. Transcept Pharmaceuticals Inc ( TSPT), Tranzyme Inc ( TZYM), Siga Technologies Inc ( SIGA), and Somaxon Pharmaceuticals Inc ( SOMX) were all winners today within the drugs industry with Pfizer Inc ( PFE) being today's featured drugs winner. Pfizer Inc rose 9 cents (0.5%) to $17.42 on average volume. Throughout the day, 52.2 million shares of Pfizer Inc exchanged hands as compared to its average daily volume of 52.8 million shares.

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. Pfizer Inc has a market cap of $137.9 billion and is part of the health care sector. The company has a P/E ratio of 16.5, above the average drugs industry P/E ratio of 16.4 and below the S&P 500 P/E ratio of 17.7. Shares are down 1% year to date as of the close of trading on Monday.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, expanding profit margins and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the negative front, Cormedix Inc ( CRMD), Uluru Inc ( ULU), CEL-SCI Corporation ( CVM), and Palatin Technologies Inc ( PTN) were all losers within the drugs industry with Vertex Pharmaceuticals ( VRTX) being today's drugs industry Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).